The Association of Protein-Energy Adequacy With Mortality in Critically Ill Patients With Acute Kidney Injury.

U

University of Malaya

Status

Unknown

Conditions

Acute Kidney Injury
Critical Illness

Study type

Observational

Funder types

Other

Identifiers

NCT04533100
MREC ID NO: 2018222-6043

Details and patient eligibility

About

This is a prospective observational single-center study in which the association of Protein-Energy Adequacy and 28-Days of Mortality among critically ill patients with Acute Kidney Injury, AKI will be investigated. The association of Protein-Energy adequacy with a length of ICU and hospital stay, total ventilator, and inotropic drug days among critically ill patients with AKI also will be investigated.

Full description

Patients with Acute Kidney Injury, AKI are probably more exposed to the risk of malnutrition especially if they undergo Renal Replacement Therapy, RRT. Optimization of nutrients especially energy and protein can ensure a better health outcome for critically ill patients with AKI. Moreover, there is no research on the association of Protein- Energy adequacy with mortality among critically ill patients with AKI in Malaysia. So, the main purpose of this study is to investigate the relationship of Protein-Energy adequacy with mortality among critically ill patients with AKI Subjects will be recruited upon admission in ICU after fulfilling the inclusion and exclusion criteria. They will be follow up from day 1 until day 14 or until ICU Discharge. Data including Demographic, Clinical, Laboratory, and Nutritional Status will be recorded. On Day 28, the outcome data including Mortality, length of ICU Stay, and Length of Ventilator day will be recorded.

Enrollment

185 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who are 18 years old and older
  • Patients who are admitted to the participating ICU.
  • Patients who are mechanically ventilated.

Exclusion criteria

  • Patients who are less than 18 years old
  • End-stage renal disease patients
  • Patients undergo kidney transplantation within 3 months before ICU admission
  • Pregnant patients
  • The patient is moribund with expected death within 24 hour or whom survival to 28 days is unlikely due to uncontrollable comorbidity (cardiac, pulmonary or hepatic end-stage disease; hepatorenal syndrome; poorly controlled cancer; severe post-anoxic encephalopathy and others)
  • Prior treatment with RRT within 30 days
  • Anticipated alive ICU discharge within 24 hours
  • Readmission to the ICU during the same hospitalization episode.

Trial contacts and locations

1

Loading...

Central trial contact

MOHAMAD IRFAN OTHMAN JAILANI, DIETETICS; MOHD SHAHNAZ HASAN, MBBS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems